secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENEREX PHARMA, INC. (RGPX)
CIK:        0001357878
Form:       8-K
Filed at:   2025-04-02T23:59:59+00:00
Accession:  0001472375-25-000037
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Regenerex Pharma appoints Kenneth Perry as CFO; Brent Wilson resigns effective March 31, 2025
--------------------------------------------------------------------------------

- Kenneth W. Perry appointed CFO effective March 31, 2025; 39 years of healthcare finance experience.
- Brent Wilson resigned as CFO on March 31, 2025, citing personal reasons.
- Perry holds an MBA in Finance from Mississippi State and a BS in Accounting from Tennessee Tech.
- Previously served as Division CFO for HCA and founded Lasis Healthcare; multiple award-winning CFO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357878/000147237525000037/0001472375-25-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357878/000147237525000037/ixform8k.htm
  HTML page:      https://secwatch.observer/filing/0001472375-25-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer